BridgeMD
Prevention study for Cervical Cancer
Official title Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India
ClinicalTrials.gov ID: NCT07209917
What this study is testing
- What it's testing
- Cervical cancer (CC) remains one of the most common malignancies among women in India, with nearly 100,000 women diagnosed annually and over 60,000 preventable deaths annually. With high-risk human papillomavirus (HR-HPV) as the causative agent for CC, one risk factor that places women at high risk for CC is human immunodeficiency virus (HIV), as impaired immune response against Human papillomavirus (HPV) may result in persistent HR-HPV infection, a critical risk factor for progression of HPV-related cervical oncogenesis.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 50, women only
You may be able to join if
- WLH, 25 - 50 years of age; based on HIV-based guidelines;
- Receiving ART for \> 12 months to ensure medication stabilization, and ensure any impact on the cervical cancer outcomes will not be attributed...
- Screened as HPV positive by RT-PCR (Reverse Transcription Polymerase Chain Reaction) for oncogenic genes; and assessed to be VIA negative;
- Have not participated in Phase I Formative Study.
You likely can't join if
- Pregnant or lactating women due to hormonal and dietary guideline differences;
- Women older than age 50. These women will be immediately referred to a gynecology specialist.
The study team makes the final eligibility decision.
Where it's taking place
- Bangalore, Karnataka, India
- Bengaluru, Karnataka, India
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 25 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bangalore, Karnataka, India; Bengaluru, Karnataka, India. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.